Antimicrobial

Digital Wound Management Devices Market to Reach USD 3,594.49 million By 2032, Growing At An 5.03% CAGR – Credence ResearchDigital Wound Management Devices Market to Reach USD 3,594.49 million By 2032, Growing At An 5.03% CAGR – Credence Research

Digital Wound Management Devices Market to Reach USD 3,594.49 million By 2032, Growing At An 5.03% CAGR – Credence Research

PUNE, India, May 5, 2025 /PRNewswire/ -- The global Digital Wound Management Devices Market was valued at USD 2,415.89 million…

1 month ago
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of DirectorsVaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors

SAN CARLOS, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines…

1 month ago
Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025

Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025

FORT WORTH, TX, April 23, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical…

2 months ago
Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot InfectionsRecce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections

Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections

Human Research Ethics Committee (HREC) approval received to allow up to 20 additional patients access to RECCE® 327 Topical Gel…

2 months ago
Best Berberine Supplement: Top Berberine Supplements For Weight Loss & Blood Sugar From Sugar DefenderBest Berberine Supplement: Top Berberine Supplements For Weight Loss & Blood Sugar From Sugar Defender

Best Berberine Supplement: Top Berberine Supplements For Weight Loss & Blood Sugar From Sugar Defender

Best Berberine Supplement for Weight loss and Blood sugar. It is used for centuries in traditional medicine, berberine is now…

2 months ago
Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of DirectorsPhathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

FLORHAM PARK, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing…

2 months ago
Spectrum Vascular Welcomes New Executive LeadershipSpectrum Vascular Welcomes New Executive Leadership

Spectrum Vascular Welcomes New Executive Leadership

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Spectrum Vascular (“Spectrum” or the “Company”), a provider of vascular access and medication management products designed to…

2 months ago
Microban International Wins Silver Edison Award for Sustainable Antimicrobial Technology Ascera™Microban International Wins Silver Edison Award for Sustainable Antimicrobial Technology Ascera™

Microban International Wins Silver Edison Award for Sustainable Antimicrobial Technology Ascera™

HUNTERSVILLE, N.C., April 10, 2025 /PRNewswire/ -- Microban International, the leader in antimicrobial solutions, has been awarded the silver Edison…

2 months ago
Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant RecipientsTheriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

Interim blinded safety and pharmacokinetic data to be presented at the Congress of the European Society of Clinical Microbiology and…

2 months ago
Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to ShareholdersRecce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders

Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders

A$5.0 million commitment received from Australian-based private investorA$10.8 million Entitlement Offer at the same offer price as the placementFunds to…

2 months ago